摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

[[2-chloro-1-(2-thiazolyl)ethenyl]oxy]tri-isopropylsilane | 556025-91-3

中文名称
——
中文别名
——
英文名称
[[2-chloro-1-(2-thiazolyl)ethenyl]oxy]tri-isopropylsilane
英文别名
2-[1-tri-isopropylsilyloxy-2-chloro-vinyl]-thiazole;2-[1-Tri-isopropylsilyloxy-2-chloro-vinyl]-thiazole;[2-chloro-1-(1,3-thiazol-2-yl)ethenoxy]-tri(propan-2-yl)silane
[[2-chloro-1-(2-thiazolyl)ethenyl]oxy]tri-isopropylsilane化学式
CAS
556025-91-3
化学式
C14H24ClNOSSi
mdl
——
分子量
317.955
InChiKey
UAULIEAQEIFHAY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    5.87
  • 重原子数:
    19
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.64
  • 拓扑面积:
    50.4
  • 氢给体数:
    0
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    [[2-chloro-1-(2-thiazolyl)ethenyl]oxy]tri-isopropylsilane 在 [ruthenium(II)(η6-1-methyl-4-isopropyl-benzene)(chloride)(μ-chloride)]2(1S,2S)-(+)-N-对甲苯磺酰基-1,2-二苯基乙二胺 甲酸氢氟酸三乙胺 作用下, 以 N,N-二甲基甲酰胺乙腈 为溶剂, 反应 4.5h, 生成 (R)-2-(1-hydroxy-2-chloroethyl)-thiazole
    参考文献:
    名称:
    Solvent and in situ catalyst preparation impacts upon Noyori reductions of aryl-chloromethyl ketones: application to syntheses of chiral 2-amino-1-aryl-ethanols
    摘要:
    As part of medicinal chemistry efforts we found it necessary to develop general syntheses of highly enantiomerically enriched 1-aryl-2-chloroethanols and 1-aryl-2-methylaminoethanols. A survey of literature methods suggested that a truly general approach had not yet been reported, encouraging us to undertake the development of such a methodology. This study describes the design, development, and reduction to practice of a general synthesis of chiral 1-aryl-2-chloroethanols and the transformation of these entities to highly enantiomerically enriched 1-aryl-2-methylaminoethanols. Of particular importance were observations of the impact of solvent and the method of catalyst preparation on the yield and enantiomerical excess of chlorohydrins prepared via Noyori transfer hydrogenations of aryl-chloromethyl ketones. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2006.07.017
  • 作为产物:
    参考文献:
    名称:
    Solvent and in situ catalyst preparation impacts upon Noyori reductions of aryl-chloromethyl ketones: application to syntheses of chiral 2-amino-1-aryl-ethanols
    摘要:
    As part of medicinal chemistry efforts we found it necessary to develop general syntheses of highly enantiomerically enriched 1-aryl-2-chloroethanols and 1-aryl-2-methylaminoethanols. A survey of literature methods suggested that a truly general approach had not yet been reported, encouraging us to undertake the development of such a methodology. This study describes the design, development, and reduction to practice of a general synthesis of chiral 1-aryl-2-chloroethanols and the transformation of these entities to highly enantiomerically enriched 1-aryl-2-methylaminoethanols. Of particular importance were observations of the impact of solvent and the method of catalyst preparation on the yield and enantiomerical excess of chlorohydrins prepared via Noyori transfer hydrogenations of aryl-chloromethyl ketones. (c) 2006 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tetasy.2006.07.017
点击查看最新优质反应信息

文献信息

  • Pyridoquinoxaline antivirals
    申请人:——
    公开号:US20030207877A1
    公开(公告)日:2003-11-06
    The present invention provides a compound of formula I 1 or a pharmaceutically acceptable salt thereof wherein R 1 , R 2 and R 3 are as defined in the specification. The compounds are useful for the treatment of viral infections.
    本发明提供了I1式化合物或其药学上可接受的盐,其中R1、R2和R3如规范中所定义。这些化合物对于治疗病毒感染有用。
查看更多